PodParley PodParley
Patho 7: Neoplasia

EPISODE · Feb 9, 2026 · 43 MIN

Patho 7: Neoplasia

from Clinical Deep Dives · host Dr Manaan Kar Ray

This episode explores neoplasia as a disease of altered rules rather than uncontrolled chaos. Cancer does not arise because cells forget how to function, but because they acquire new priorities. Survival, replication, and persistence replace cooperation. Neoplasia is therefore not a single event, but an evolutionary process unfolding within tissues over time.The episode begins by defining neoplasia as clonal, autonomous growth that persists after removal of the initiating stimulus. The distinction between benign and malignant tumours is framed around behaviour rather than appearance alone. Benign tumours grow slowly and remain local, while malignant tumours invade, metastasise, and ultimately disrupt organ function.The molecular basis of cancer is then explored. Oncogenes, tumour suppressor genes, DNA repair genes, and apoptosis regulators are introduced as guardians of normal growth. Cancer emerges when multiple layers of control fail. The concept of multi step carcinogenesis is emphasised, showing how accumulated mutations progressively shift cellular behaviour.The hallmarks of cancer are then used as an organising framework. Sustained proliferative signalling, evasion of growth suppressors, resistance to cell death, replicative immortality, angiogenesis, invasion, metastasis, metabolic reprogramming, and immune evasion are explored as strategic adaptations rather than random features. Cancer cells are shown to reshape their environment to support continued growth.Tumour progression and metastasis are examined as dynamic processes. The episode traces how tumour cells breach basement membranes, enter circulation, survive hostile conditions, and colonise distant tissues. The importance of tumour stroma, angiogenesis, and immune interaction is highlighted, reframing cancer as a disease of ecosystems rather than isolated cells.Finally, the episode addresses clinical consequences. Paraneoplastic syndromes, cancer cachexia, grading, staging, and tumour markers are introduced as tools for understanding disease burden and prognosis. Neoplasia is presented not as a moral failure of the body, but as biology pushed beyond its cooperative limits.Key takeaways* Neoplasia represents clonal growth that escapes normal regulatory control* Malignancy is defined by invasion and metastasis rather than size alone* Cancer develops through accumulation of genetic and epigenetic alterations* Tumours evolve by interacting with and reshaping their microenvironment* Clinical impact reflects both local disruption and systemic effects This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe

NOW PLAYING

Patho 7: Neoplasia

0:00 43:37

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Oncology Today with Dr Neil Love Research To Practice Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice. My Take On It with Your Angelic Karma® Your Angelic Karma Here we take a look at how the United States measures alongside other First World Nations. + taking a deep dive into the science -The Report Metagenics Institute Podcast Metagenics Welcome to the Metagenics Institute Podcast where Healthcare Practitioners can hear innovative, cutting-edge information from leading experts from around the world. Join your host, Nathan Rose, to explore the latest evidence in Natural Health, challenge and debunk industry myths and offer practical, tangible, clinical tools which will transform your practice. The Syndicate Blogcast: Startups | Startup Investing | Tech News | Angel Investors | VC | Venture Capital | Private Equity | Crowdfunding | Fundraising Matt Ward - Serial Entrepreneur | Angel Investor | Startup Advisor | Amazon Ecommerce The Syndicate Blogcast show is an extension of The Syndicate podcast, featuring long form articles on the future technology, ecommerce, business and life. The mini-sodes deconstruct high level startup, business and tech issues to help investors and operators better understand and win the market. Recurring topics include: Facebook, Google, Amazon, Apple, Ecommerce, Blockchains, ICOs, Cryptocurrencies, Marketing, Fundraising, Venture Capital, Startup Challenges, Business Development and more. The Blogcast comes in addition to The Syndicate - the place where investors and startups combine to create crazy businesses and even crazier returns. The Syndicate podcast is a deep dive on the angel investors and VCs behind the big name startups. We interview the best and brightest investors, syndicate leads, GPs, limited partners and startup founders to create an original, off the cuff discussion on startup investing.
URL copied to clipboard!